Walleye Capital’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Walleye Capital's ELV Position: Q3 2026 in Review
Walleye Capital increased its Elevance Health (ELV) stake by 1,809% in Q3 2026, buying an estimated $10M and bringing the position to 26,342 shares worth $10.2M. The position accounts for 0.01% of the portfolio, ranked #1247.
Walleye Capital first reported a position in ELV in Q3 2018 and has held it in 19 quarters since. The position peaked at $38.3M in Q4 2025. 1,610 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Walleye Capital held 26,342 shares of Elevance Health worth $10.2M as of Q3 2026.
- Walleye Capital bought 24,962 Elevance Health shares in Q3 2026, an estimated $10M.
- Elevance Health made up 0.01% of Walleye Capital's portfolio in Q3 2026, its #1247 holding.
- Walleye Capital first reported a position in Elevance Health in Q3 2018 and has held it in 19 quarters since.
- Walleye Capital's Elevance Health position peaked at $38.3M in Q4 2025.
- 1,610 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.